Robb Gary Charles

Average Profitability
72.23%
Insider Buys Quantity
1
Insider Buys Sum
$54,588.24
Insider Sells Quantity
25
Insider Sells Sum
$11.72M

Insider Activity of Robb Gary Charles

According to the SEC Form 4 filings, Robb Gary Charles, being in a position of

  1. Chief Business Officer at Corcept Therapeutics Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 43694 shares for $1.52M,
    over all time since 2017-05-04, has bought 5600 shares for $54,588, and sold 462710 shares for $11.72M.

The largest purchase of all time was on 2017-05-04 and amounted to 5600 shares of Corcept Therapeutics Incorporated for $54,588.

The largest sale of all time was on 2021-02-12 and amounted to 112100 shares of Corcept Therapeutics Incorporated for $3.16M.

Biography of Robb Gary Charles

No biography is available at this moment.

2024-10-01SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0113%
$46.28$509,080+0.19%
2024-08-26SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
3,101
0.003%
$35.71$110,737+28.14%
2024-07-01SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0109%
$32.49$357,3900%
2024-05-28SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0102%
$30.39$334,294+9.71%
2023-12-06SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
6,212
0.006%
$27.01$167,786+3.14%
2023-12-05SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
1,381
0.0013%
$26.27$36,277+5.18%
2023-09-19SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
5,000
0.0048%
$32.74$163,677-19.65%
2023-05-10SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
14,000
0.013%
$24.07$336,980+3.38%
2023-05-09SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
30,000
0.0279%
$23.87$716,100+4.11%
2022-11-23SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
186
0.0002%
$26.03$4,842-9.77%
2022-11-22SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
4,814
0.0045%
$26.03$125,308-9.87%
2022-11-18SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
13,401
0.0124%
$26.43$354,188-11.54%
2022-11-17SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
10,000
0.0093%
$26.06$260,600-9.63%
2022-09-07SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
50,000
0.0462%
$26.06$1.3M-10.86%
2022-07-06SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
45,000
0.0417%
$26.00$1.17M-8.78%
2022-05-17SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
6,127
0.0058%
$19.57$119,928+21.74%
2022-03-17SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
4,988
0.0047%
$24.67$123,054-1.51%
2021-09-15SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
47,853
0.0415%
$20.49$980,742+7.32%
2021-09-14SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
806
0.0007%
$20.76$16,736+5.99%
2021-09-13SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
6,341
0.0055%
$20.89$132,445+3.45%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.